Quest Diagnostics Stock (NYSE: DGX) stock price, news, charts, stock research, profile.
Open | $138.120 |
Close | $138.420 |
Volume / Avg. | 569.562K / 977.468K |
Day Range | 137.401 - 138.960 |
52 Wk Range | 119.590 - 145.580 |
Market Cap | $15.377B |
P/E Ratio | 18.595 |
Dividend Yield | 2.170% |
Exchange | NYSE |
RSI | 61 |
Short Interest | 3.11% |
Days to Cover | 3.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Quest Diagnostics (NYSE: DGX) through any online brokerage.
Other companies in Quest Diagnostics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Hims & Hers Health (NYSE:HIMS), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Quest Diagnostics (NYSE: DGX) was reported by Barclays on Thursday, April 25, 2024. The analyst firm set a price target for 144.00 expecting DGX to rise to within 12 months (a possible 4.03% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Quest Diagnostics (NYSE: DGX) is $138.42 last updated May 10, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on April 22, 2024 to stockholders of record on April 5, 2024.
Quest Diagnostics’s Q2 earnings are confirmed for Wednesday, July 24, 2024.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.